News
Hosted on MSN7mon
Inspire Medical gains on GLP-1 prospectsInspire Medical Systems (NYSE:INSP) traded higher on Wednesday after MedTech's CEO argued that the GLP-1 class of weight loss drugs could benefit its sleep apnea therapy business. "We are excited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback